Capecitabine: Fixed Daily Dose and Continuous (Noncyclic) Dosing Schedule
- 1 January 2004
- journal article
- research article
- Published by Taylor & Francis in Cancer Investigation
- Vol. 22 (5) , 713-717
- https://doi.org/10.1081/cnv-200032976
Abstract
(2004). Capecitabine: Fixed Daily Dose and Continuous (Noncyclic) Dosing Schedule. Cancer Investigation: Vol. 22, No. 5, pp. 713-717.Keywords
This publication has 10 references indexed in Scilit:
- Phase I Trial Evaluating the Concurrent Combination of Radiotherapy and Capecitabine in Rectal CancerJournal of Clinical Oncology, 2002
- First-line oral capecitabine therapy in metastatic colorectal cancer: a favorable safety profile compared with intravenous5-fluorouracil/leucovorinAnnals of Oncology, 2002
- Oral Capecitabine Compared With Intravenous Fluorouracil Plus Leucovorin in Patients With Metastatic Colorectal Cancer: Results of a Large Phase III StudyJournal of Clinical Oncology, 2001
- Comparison of Oral Capecitabine Versus Intravenous Fluorouracil Plus Leucovorin as First-Line Treatment in 605 Patients With Metastatic Colorectal Cancer: Results of a Randomized Phase III StudyJournal of Clinical Oncology, 2001
- Capecitabine, an Oral Fluoropyrimidine Carbamate With Substantial Activity in Advanced Colorectal Cancer: Results of a Randomized Phase II StudyJournal of Clinical Oncology, 2000
- Phase I and pharmacologic study of intermittent twice-daily oral therapy with capecitabine in patients with advanced and/or metastatic cancer.Journal of Clinical Oncology, 1998
- Preliminary studies of a novel oral fluoropyrimidine carbamate: capecitabine.Journal of Clinical Oncology, 1998
- Fluorouracil in colorectal cancer--a tale of two drugs: implications for biochemical modulation.Journal of Clinical Oncology, 1997
- A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: a Mid-Atlantic Oncology Program Study.Journal of Clinical Oncology, 1989